At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 903 enrolled
Drug / intervention
Adapalene and Benzoyl Peroxide Gel +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris
In Brief
A Phase 3 clinical trial evaluating Adapalene and Benzoyl Peroxide Gel, Adapalene and Benzoyl Peroxide Gel (Reference), and 1 other intervention for Acne. Completed, enrolled 903 participants.
Detailed Summary
The purpose of this study is to compare the safety and bioequivalence of Perrigo's product to an FDA approved product for the treatment acne vulgaris.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2011
Primary CompletionAug 2012
First PostedAug 2015
TodayJul 2026
First PostedAug 17, 2015
Enrollment StartDec 1, 2011
Primary CompletionAug 1, 2012
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 10.9 years ago
Interventions
Adapalene and Benzoyl Peroxide Geldrug
Adapalene and Benzoyl Peroxide Gel (Reference)drug
Placebo geldrug